PCP
ALXN

Proficio Capital Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Proficio Capital Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-233
Closed -$31K – 1815
2019
Q2 		$31K Sell
233
-33
-12% -$4.25K 0.01% 531
2019
Q1 		$36K Buy
266
+140
+111% +$17.4K 0.01% 452
2018
Q4 		$12K Sell
126
-125
-50% -$14.8K 0.01% 702
2018
Q3 		$35K Hold
251
– – 0.01% 435
2018
Q2 		$31K Buy
251
+20
+9% +$2.34K 0.01% 477
2018
Q1 		$26K Sell
231
-51
-18% -$6.1K 0.01% 521
2017
Q4 		$34K Sell
282
-18
-6% -$2.19K 0.01% 444
2017
Q3 		$42K Buy
300
+8
+3% +$1.09K 0.02% 425
2017
Q2 		$40K Buy
292
+115
+65% +$13.4K 0.02% 439
2017
Q1 		$18K Buy
177
+14
+9% +$1.8K 0.01% 655
2016
Q4 		$20K Buy
163
+128
+366% +$15.7K 0.01% 450
2016
Q3 		$4K Buy
35
+11
+46% +$1.42K ﹤0.01% 784
2016
Q2 		$3K Buy
24
+23
+2,300% +$3.26K ﹤0.01% 802
2016
Q1 		$0 Sell
1
-45
-98% -$6.61K ﹤0.01% 1193
2015
Q4 		$9K Buy
+46
New +$8.04K 0.01% 298

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Proficio Capital Partners's ALXN Position: Q3 2019 in Review

Proficio Capital Partners sold out of Alexion Pharmaceuticals (ALXN) in Q3 2019, closing a stake of 233 shares — an estimated $31K sold.

Proficio Capital Partners first reported a position in ALXN in Q4 2015 and held it in 15 quarters. The position peaked at $42K in Q3 2017. 648 funds tracked by Wall St. Rank hold ALXN as of Q3 2019.

  • Proficio Capital Partners reported no remaining Alexion Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 233 Alexion Pharmaceuticals shares in Q3 2019, an estimated $31K.
  • Proficio Capital Partners first reported a position in Alexion Pharmaceuticals in Q4 2015 and held it in 15 quarters.
  • Proficio Capital Partners's Alexion Pharmaceuticals position peaked at $42K in Q3 2017.
  • 648 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.